Analysis and Evaluation of the Inhibitory Mechanism of a Novel Angiotensin-I-Converting Enzyme Inhibitory Peptide Derived from Casein Hydrolysate

Journal of Agricultural and Food Chemistry

Volumn 66, Issue 16, 2018, Pages 4139-4144

  Tu, Maolin ^a,b   Liu, Hanxiong ^a   Zhang, Ruyi ^a   Chen, Hui ^a   Mao, Fengjiao ^a   Cheng, Shuzhen ^a,c   Lu, Weihong ^b   Du, Ming ^a,b  

^a DALIAN POLYTECHNIC UNIVERSITY   (China)

^b HARBIN INSTITUTE OF TECHNOLOGY   (China)

^c CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

ACE inhibitory activity; casein; CE TOF MS MS; in silico; molecular docking; peptide

Indexed keywords

CAPILLARY ELECTROPHORESIS; CASEIN; ENZYMES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR MODELING;

ACE-INHIBITORY ACTIVITY; ANALYSIS AND EVALUATION; ANGIOTENSIN I-CONVERTING ENZYME; IN-SILICO; INHIBITORY CONCENTRATION; MOLECULAR DOCKING; QUADRUPOLE TIME-OF-FLIGHT TANDEM MASS SPECTROMETRIES; ULTRA-FILTRATION MEMBRANES;

PEPTIDES;

CASEIN; CASEIN HYDROLYSATE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PEPTIDE;

ANIMAL; CHEMISTRY; HYDROLYSIS; KINETICS; LEPORIDAE; MOLECULAR DOCKING; TANDEM MASS SPECTROMETRY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CASEINS; HYDROLYSIS; KINETICS; MOLECULAR DOCKING SIMULATION; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; RABBITS; TANDEM MASS SPECTROMETRY;

EID: 85046033378     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.8b00732     Document Type: Article

References (27)

1. Deshwal, S.; Di Sante, M.; Di Lisa, F.; Kaludercic, N. Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease. Curr. Opin. Pharmacol. 2017, 33, 64-69, 10.1016/j.coph.2017.04.003
2. Micha, R.; Penalvo, J. L.; Cudhea, F.; Imamura, F.; Rehm, C. D.; Mozaffarian, D. Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. J. Am. Med. Assoc. 2017, 317, 912-924, 10.1001/jama.2017.0947
3. Cannon, C. P. Cardiovascular disease and modifiable cardiometabolic risk factors. Clin. Cornerstone. 2008, 9, 24-41, 10.1016/S1098-3597(09)62037-8
4. Gu, Q.; Dillon, C. F.; Burt, V. L.; Gillum, R. F. Association of hypertension treatment and control with all-cause and cardiovascular disease mortality among US adults with hypertension. Am. J. Hypertens. 2010, 23, 38-45, 10.1038/ajh.2009.191
5. Ettehad, D.; Emdin, C. A.; Kiran, A.; Anderson, S. G.; Callender, T.; Emberson, J.; Chalmers, J.; Rodgers, A.; Rahimi, K. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet 2016, 387, 957-967, 10.1016/S0140-6736(15)01225-8
6. Ahmad, I.; Yanuar, A.; Mulia, K.; Mun'Im, A. Review of angiotensin-converting enzyme inhibitory assay: Rapid method in drug discovery of herbal plants. Pharmacogn. Rev. 2017, 11, 1-7, 10.4103/phrev.phrev-45-16
7. Negraes, P. D.; Trujillo, C. A.; Pillat, M. M.; Teng, Y. D.; Ulrich, H. Roles of kinins in the nervous system. Cell Transplant 2015, 24, 613-623, 10.3727/096368915X687778
8. Rai, A. K.; Sanjukta, S.; Jeyaram, K. Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension. Crit. Rev. Food Sci. Nutr. 2017, 57, 2789-2800, 10.1080/10408398.2015.1068736
9. Capriotti, A. L.; Cavaliere, C.; Piovesana, S.; Samperi, R.; Laganà, A. Recent trends in the analysis of bioactive peptides in milk and dairy products. Anal. Bioanal. Chem. 2016, 408, 2677-2685, 10.1007/s00216-016-9303-8
10. Field, K. L.; Kimball, B. A.; Mennella, J. A.; Beauchamp, G. K.; Bachmanov, A. A. Avoidance of hydrolyzed casein by mice. Physiol. Behav. 2008, 93, 189-199, 10.1016/j.physbeh.2007.08.010
11. Ibrahim, H. R.; Ahmed, A. S.; Miyata, T. Novel angiotensin-converting enzyme inhibitory peptides from caseins and whey proteins of goat milk. J. Adv. Res. 2017, 8, 63-71, 10.1016/j.jare.2016.12.002
12. Wu, J.; Aluko, R. E.; Nakai, S. Structural requirements of angiotensin I-converting enzyme inhibitory peptides: Quantitative structure-activity relationship modeling of peptides containing 4-10 amino acid residues. QSAR Comb. Sci. 2006, 25, 873-880, 10.1002/qsar.200630005
13. Wang, Y.; Jiang, Y.; Yin, Y.; Liu, J.; Ding, L.; Liu, J.; Zhang, T. Identification and inhibitory mechanism of angiotensin I-converting enzyme inhibitory peptides derived from bovine hemoglobin. Protein J. 2017, 36, 166-173, 10.1007/s10930-017-9708-z
14. Tu, M.; Wang, C.; Chen, C.; Zhang, R.; Liu, H.; Lu, W.; Jiang, L.; Du, M. Identification of a novel ACE-inhibitory peptide from casein and evaluation of the inhibitory mechanisms. Food Chem. 2018, 256, 98-104, 10.1016/j.foodchem.2018.02.107
15. Fu, Y.; Alashi, A. M.; Young, J. F.; Therkildsen, M.; Aluko, R. E. Enzyme inhibition kinetics and molecular interactions of patatin peptides with angiotensin I-converting enzyme and renin. Int. J. Biol. Macromol. 2017, 101, 207-213, 10.1016/j.ijbiomac.2017.03.054
16. S2-casein. FEBS Lett. 2002, 531, 369-374, 10.1016/S0014-5793(02)03576-7
17. Murray, B.; FitzGerald, R. Angiotensin converting enzyme inhibitory peptides derived from food proteins: Biochemistry, bioactivity and production. Curr. Pharm. Des. 2007, 13, 773-791, 10.2174/138161207780363068
18. Mora, L.; Escudero, E.; Aristoy, M. C.; Toldrá, F. A peptidomic approach to study the contribution of added casein proteins to the peptide profile in spanish dry-fermented sausages. Int. J. Food Microbiol. 2015, 212, 41-48, 10.1016/j.ijfoodmicro.2015.05.022
19. López-Expósito, I.; Quirós, A.; Amigo, L.; Recio, I. Casein hydrolysates as a source of antimicrobial, antioxidant and antihypertensive peptides. Lait 2007, 87, 241-249, 10.1051/lait:2007019
20. Maruyama, S.; Miyoshi, S.; Tanaka, H. Angiotensin I-converting enzyme inhibitors derived from Ficus carica. Agric. Biol. Chem. 1989, 53, 2763-2767, 10.1080/00021369.1989.10869725
21. Natesh, R.; Schwager, S. L.; Sturrock, E. D.; Acharya, K. R. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 2003, 421, 551-554, 10.1038/nature01370
22. Gupta, S.; Kapoor, P.; Chaudhary, K.; Gautam, A.; Kumar, R.; Raghava, G. P. In silico approach for predicting toxicity of peptides and proteins. PLoS One 2013, 8, e73957, 10.1371/journal.pone.0073957
23. Balakin, K. V.; Savchuk, N. P.; Tetko, I. V. In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: Trends, problems and solutions. Curr. Med. Chem. 2006, 13, 223-241, 10.2174/092986706775197917
24. Wu, J.; Liao, W.; Udenigwe, C. C. Revisiting the mechanisms of ACE inhibitory peptides from food proteins. Trends Food Sci. Technol. 2017, 69, 214-219, 10.1016/j.tifs.2017.07.011
25. Fitzgerald, R. J.; Murray, B. A.; Walsh, D. J. Hypotensive peptides from milk proteins. J. Nutr. 2004, 134, 980S-988S, 10.1093/jn/134.4.980S
26. Ko, S. C.; Kang, M. C.; Lee, J. K.; Byun, H. G.; Kim, S. K.; Lee, S. C.; Jeon, B. T.; Park, P. J.; Jung, W. K.; Jeon, Y. J. Effect of angiotensin I-converting enzyme (ACE) inhibitory peptide purified from enzymatic hydrolysates of Styela plicata. Eur. Food Res. Technol. 2011, 233, 915-922, 10.1007/s00217-011-1585-7
27. Girgih, A. T.; He, R.; Aluko, R. E. Kinetics and molecular docking studies of the inhibitions of angiotensin converting enzyme and renin activities by hemp seed (Cannabis sativa L.) peptides. J. Agric. Food Chem. 2014, 62, 4135-4144, 10.1021/jf5002606